Harbor Capital Advisors, Inc. Alkermes Plc. Transaction History
Harbor Capital Advisors, Inc.
- $765 Million
- Q1 2024
A detailed history of Harbor Capital Advisors, Inc. transactions in Alkermes Plc. stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 21,700 shares of ALKS stock, worth $527,093. This represents 0.08% of its overall portfolio holdings.
Number of Shares
21,700
Previous 9,903
119.13%
Holding current value
$527,093
Previous $274,000
114.23%
% of portfolio
0.08%
Previous 0.05%
Shares
7 transactions
Others Institutions Holding ALKS
# of Institutions
357Shares Held
180MCall Options Held
522KPut Options Held
463K-
Black Rock Inc. New York, NY29.2MShares$709 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.2MShares$490 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.9MShares$362 Million0.07% of portfolio
-
State Street Corp Boston, MA9MShares$219 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.33MShares$202 Million0.03% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $3.99B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...